close
Advertisement
Can't connect right now! retry

add The News to homescreen

tap to bring up your browser menu and select 'Add to homescreen' to pin the The News web app

Got it!

add The News to homescreen

tap to bring up your browser menu and select 'Add to homescreen' to pin the The News web app

Got it!
 
May 5, 2021

Covid-19 may last until mid-2022: BioNTech founders

Top Story

 
May 5, 2021

ISLAMABAD: The surge of coronavirus infections in developing countries such as India amid a relative scarcity of vaccine supply means that the pandemic will keep spreading until mid-2022, according to the inventors of the first Covid-19 vaccine authorised in the West.

Because of the urgency, authorities should consider such measures as mixing and matching vaccines from different manufacturers, said the founders of BioNTech SE, according to international media reports.

The German company teamed up with Pfizer Inc. to test, manufacture and distribute its vaccine. “We need to ensure really high vaccination rates world-wide. Otherwise, no one will be safe,” said U ur ahin, BioNTech’s chief executive officer. He said the pandemic would only end when herd immunity is accomplished world-wide.

“By mid-2022,even regions with high density populations like India will reach a high rate of vaccination and herd immunity,” Dr ahin said.

“We will see in the next 12 months an increasing number of industrial, developing and low-income countries reaching this type of herd immunity just by increasing the manufacturing capacity of the currently existing players and adding new manufacturing sites.”